Viewing nowClodrine Tablets (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Independent Bio Pharmaceutical Co., Ltd.

MFDS item code 201908185 · Approved 2019.12.02 · Insurance code 057700530
Improvement of acute coronary syndrome and atherosclerotic symptoms; prevention of thromboembolism in atrial fibrillation
This medication is used to improve symptoms of atherosclerotic diseases such as ischemic stroke, myocardial infarction, and peripheral artery disease. It also helps reduce the risk of cardiovascular complications in patients with acute coronary syndrome, such as unstable angina or non-Q wave myocardial infarction. In patients with atrial fibrillation who have vascular risk factors and cannot use vitamin K antagonists, it is effective in reducing the risk of thrombosis, such as stroke. This medicine plays an important role in the improvement and prevention of these cardiovascular problems.
○ Adults 1. Patients with ischemic stroke, myocardial infarction, or peripheral arterial disease: Administer 75 mg of clopidogrel orally once daily. 2. Patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): On the day treatment with this medicine is initiated, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. Patients with atrial fibrillation: Administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate hepatic disease with a bleeding diathesis is limited. This medicine may be administered regardless of food intake.
This medicine helps blood flow by preventing platelets from aggregating in the blood. Caution is needed as individuals genetically lacking a specific enzyme (CYP2C19) may not respond adequately to this medication. Additionally, it is advisable not to co-administer with medications that activate the CYP2C19 enzyme as this may increase the risk of bleeding. Patients with allergies to this medication, those with bleeding disorders, patients with severe liver damage, breastfeeding women, and those with lactose intolerance should not take this medication. Patients at higher risk for bleeding, those with impaired liver or kidney function, the elderly, underweight patients, and patients with specific allergies should use this medication with caution. If surgery is planned or if there are conditions that pose a bleeding risk, the medication should be discontinued 5 to 7 days before the surgery, and medical personnel should be notified immediately if bleeding symptoms occur. This medication can cause bleeding, and if any bleeding symptoms occur, it is imperative to go to the hospital for blood tests. During the intake of this medication, it is important to consult with a doctor or pharmacist before starting or stopping any new medications, and any bleeding symptoms or adverse reactions should be reported immediately.
Hemorrhage, gastrointestinal bleeding, hospitalization-required bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major bleeding, life-threatening bleeding, hemorrhagic stroke, transfusion requirement, organ dysfunction, vision loss, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, syncope, palpitations, weakness, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory loss, neuralgia, sensory disturbance, dizziness, constipation, vomiting, increased liver enzymes, gout, hyperuricemia, non-protein nitrogen increase, arthritis, arthrosis, anxiety, insomnia, anemia, bloody stools, cerebral hemorrhage, gum bleeding, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, distension, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, stomatitis, hepatitis, acute liver failure, petechial papules, erythematous skin rash, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, drug rash, lichen planus, myalgia, glomerulopathy, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air and moisture; hence, it should be stored in a tightly closed container. It is also safe to store it at room temperature between 1 and 30 degrees Celsius, avoiding extremely hot or cold places.
Pink round film-coated tablets
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Independent Bio Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.